DLD Asset Management »

Kymera Therapeutics shares owned by DLD Asset Management

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $287k 2.5k 114.71

More positions owned by DLD Asset Management

Echostar Corp Note 3.875%11/3 (Principal)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Wolfspeed Note 2.500% 6/1 (Principal)
Stride Note 1.125% 9/0 (Principal)
Centrus Energy Corp Note 2.250%11/0 (Principal)
Akamai Technologies Note 0.250% 5/1 (Principal)
On Semiconductor Corp Note 5/0 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Marathon Digital Holdings In Put Option (MARA)
Eli Lilly & Co. Call Option (LLY)
Firstenergy Corp Note 3.625% 1/1 (Principal)
Encore Cap Group Note 4.000% 3/1 (Principal)
Patrick Inds Note 1.750%12/0 (Principal)
Super Micro Computer Com New Put Option (SMCI)
Merit Med Sys Note 3.000% 2/0 (Principal)

View all positions for DLD Asset Management

Top funds holding Kymera Therapeutics

FMR
Baker Bros. Advisors
venBio Select Advisor
T. Rowe Price Associates
BlackRock
BVF
Wellington Management Company
Vanguard Portfolio Management
Siren
Vanguard Capital Management
Atlas Venture Life Science Advisors
State Street Corporation
Geode Capital Management
Capital Research Global Investors
Goldman Sachs Group

View all funds holding Kymera Therapeutics